Dr. Martens PLC Ordinary Shares (DOCS)

Industry Footwear & Accessories


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

74.20p

Buy

74.40p

arrow-up15.45p (+25.77%)

Prices updated at 05 Jun 2025, 19:22 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Consumer Cyclical
Industry
Footwear & Accessories
Chairman
Mr. Paul Mason
CEO
Mr. Ije Nwokorie
Most recent earnings
31 Mar 2024
Fiscal year end
31 Mar 2024
Employees
3,650
Head office
28 Jamestown Road
London
United Kingdom
NW1 7BY
mobile
+44 2039086901
letter
company.secretariat@drmartens.com

Key personnel

Salary
Ms. Lynne Marie Weedall
Non-Executive Director, Senior Independent Non-Executive Director
-
Mr. Paul Mason
Non-Executive Director, Chairman
-
Mr. Andrew John Harrison
Non-Executive Director
-
Ms. Robyn Perriss
Non-Executive Director
-
Mr. Ian Rogers
Non-Executive Director
-
Mr. Giles Wilson
Executive Director, Chief Financial Officer
-
Mr. Ije Nwokorie
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Artemis Investment Management LLP64,556,008
UWS Artemis Income B53,159,115
Franklin Templeton Investments50,519,814
Fidelity Management & Research Company LLC28,800,774
Fidelity Low-Priced Stock Fund24,032,019

Director dealings

Action
12 May 2025Transfer in
12 May 2025Purchase
12 May 2025Purchase
12 May 2025Transfer in
15 Apr 2025Sale
15 Apr 2025Transfer in
11 Apr 2025Transfer in
11 Apr 2025Purchase
11 Apr 2025Purchase
11 Apr 2025Transfer in
08 Apr 2025D
08 Apr 2025D
25 Mar 2025Purchase
11 Mar 2025Transfer in
11 Mar 2025Purchase
11 Mar 2025Transfer in
11 Mar 2025Purchase
11 Feb 2025Transfer in
11 Feb 2025Purchase
11 Feb 2025Transfer in
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.